Trial Details
TERMINATEDBasic Information
| Clinical ID | c4201 |
|---|---|
| Identifier | NCT00882414 |
| Trial Title | Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Thrombocytosis|Iron-Deficiency Anemia |
| Interventions | DRUG: FERINJECT® (Ferric carboxymaltose)|DRUG: Placebo |
Participant Information
| Sponsor | Vifor Pharma |
|---|---|
| City | Vienna |
| Country/Region | Austria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2006-12 |
|---|---|
| Primary Completion Date | 2010-01 |
| Completion Date | 2010-01 |